Upstream Bio (NASDAQ: UPB) net income
Upstream Bio reported a net loss of $143.4m for fiscal 2025; in fiscal 2024 it reported a net loss of $62.8m. Earnings per share were −$2.66.
Upstream Bio's best year of the last 3 was fiscal 2023. It reported a loss in 3 of those 3 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$143.4m | — | −5,026.0% | −$2.66 |
| 2024 | −$62.8m | — | −2,650.0% | −$5.58 |
| 2023 | −$20.5m | — | −862.9% | −$12.95 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Upstream Bio net income compared with its sector
By net income for its latest fiscal year, Upstream Bio ranks 376th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Upstream Bio, −5,026.0%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 374th | Alector | −$142.9m | −679.2% |
| 375th | Alphatec | −$143.4m | −18.8% |
| 376th | Upstream Bio | −$143.4m | −5,026.0% |
| 377th | Entrada Therapeutics | −$143.8m | −565.5% |
| 378th | Charles River Laboratories | −$144.3m | −3.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Upstream Bio
- How much did Upstream Bio earn in fiscal 2025?
- Upstream Bio reported a net loss of $143.4m for fiscal 2025. In fiscal 2024 it reported a net loss of $62.8m.
- What are the earnings per share of Upstream Bio?
- They were −$2.66 in fiscal 2025, compared with −$5.58 in fiscal 2024.
- Where does Upstream Bio rank in its sector by net income?
- It ranks 376th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Upstream Bio come from?
- From the annual report (Form 10-K) that Upstream Bio files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Upstream Bio files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Upstream Bio: the Upstream Bio page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.